General Information of Drug Transporter (DT)
DT ID DTD0077 Transporter Info
Gene Name SLC10A5
Transporter Name Sodium/bile acid cotransporter 5
Gene ID
347051
UniProt ID
Q5PT55
Epigenetic Regulations of This DT (EGR)

Methylation

  Prostate cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in prostate cancer [ 1 ]

Location

5'UTR (cg24766398)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.27E+00 Statistic Test p-value: 6.60E-03; Z-score: -2.92E+00

Methylation in Case

6.57E-01 (Median) Methylation in Control 8.31E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC10A5 in prostate cancer [ 1 ]

Location

Body (cg27649194)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.34E+00 Statistic Test p-value: 2.63E-02; Z-score: 1.80E+00

Methylation in Case

5.31E-01 (Median) Methylation in Control 3.95E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Bladder cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in bladder cancer [ 2 ]

Location

TSS1500 (cg00161955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.60E+00 Statistic Test p-value: 5.49E-12; Z-score: -2.10E+01

Methylation in Case

5.38E-01 (Median) Methylation in Control 8.59E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC10A5 in bladder cancer [ 2 ]

Location

TSS1500 (cg02573176)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.01E+00 Statistic Test p-value: 1.64E-10; Z-score: -9.39E+00

Methylation in Case

2.18E-01 (Median) Methylation in Control 6.58E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC10A5 in bladder cancer [ 2 ]

Location

TSS1500 (cg26164767)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.19E+00 Statistic Test p-value: 1.49E-07; Z-score: -7.10E+00

Methylation in Case

5.74E-01 (Median) Methylation in Control 6.83E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in breast cancer [ 3 ]

Location

TSS1500 (cg02573176)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.39E+00 Statistic Test p-value: 1.11E-16; Z-score: -3.09E+00

Methylation in Case

5.32E-01 (Median) Methylation in Control 7.37E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC10A5 in breast cancer [ 3 ]

Location

TSS1500 (cg00161955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.23E+00 Statistic Test p-value: 3.31E-10; Z-score: -2.84E+00

Methylation in Case

6.72E-01 (Median) Methylation in Control 8.24E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC10A5 in breast cancer [ 3 ]

Location

TSS1500 (cg26164767)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 4.16E-03; Z-score: -9.56E-01

Methylation in Case

6.15E-01 (Median) Methylation in Control 6.75E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in colorectal cancer [ 4 ]

Location

TSS1500 (cg00161955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 3.40E-11; Z-score: -3.49E+00

Methylation in Case

7.11E-01 (Median) Methylation in Control 8.59E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC10A5 in colorectal cancer [ 4 ]

Location

TSS1500 (cg26164767)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 6.19E-05; Z-score: -1.20E+00

Methylation in Case

7.89E-01 (Median) Methylation in Control 8.24E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC10A5 in colorectal cancer [ 4 ]

Location

TSS1500 (cg02573176)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 5.73E-03; Z-score: -9.65E-01

Methylation in Case

4.29E-01 (Median) Methylation in Control 5.60E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Panic disorder

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in panic disorder [ 5 ]

Location

TSS1500 (cg00161955)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 3.18E-04; Z-score: 4.07E-01

Methylation in Case

2.25E+00 (Median) Methylation in Control 2.10E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC10A5 in panic disorder [ 5 ]

Location

1stExon (cg11065621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.31E-01 Statistic Test p-value: 4.76E-03; Z-score: -4.37E-01

Methylation in Case

-1.65E+00 (Median) Methylation in Control -1.54E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in papillary thyroid cancer [ 6 ]

Location

TSS1500 (cg02573176)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.00E-03; Z-score: -4.62E-01

Methylation in Case

8.58E-01 (Median) Methylation in Control 8.75E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in hepatocellular carcinoma [ 7 ]

Location

TSS200 (cg26685352)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 5.50E+00 Statistic Test p-value: 2.72E-17; Z-score: 9.91E+00

Methylation in Case

2.39E-01 (Median) Methylation in Control 4.34E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC10A5 in hepatocellular carcinoma [ 7 ]

Location

1stExon (cg11065621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.69E+00 Statistic Test p-value: 1.59E-09; Z-score: -1.61E+00

Methylation in Case

1.98E-01 (Median) Methylation in Control 3.35E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in lung adenocarcinoma [ 8 ]

Location

1stExon (cg11065621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 5.52E-03; Z-score: 1.86E+00

Methylation in Case

5.92E-01 (Median) Methylation in Control 4.96E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC10A5 in pancretic ductal adenocarcinoma [ 9 ]

Location

Body (cg05213116)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 7.50E-04; Z-score: 9.44E-01

Methylation in Case

7.17E-01 (Median) Methylation in Control 6.83E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples
References
1 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
6 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
7 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
8 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
9 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.